180 related articles for article (PubMed ID: 8290259)
1. Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts.
Hajnal A; Klemenz R; Schäfer R
Oncogene; 1994 Feb; 9(2):479-90. PubMed ID: 8290259
[TBL] [Abstract][Full Text] [Related]
2. Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors.
Sers C; Emmenegger U; Husmann K; Bucher K; Andres AC; Schäfer R
J Cell Biol; 1997 Feb; 136(4):935-44. PubMed ID: 9049257
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12.
Husmann K; Sers C; Fietze E; Mincheva A; Lichter P; Schäfer R
Oncogene; 1998 Sep; 17(10):1305-12. PubMed ID: 9771974
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.
Hajnal A; Klemenz R; Schäfer R
Cancer Res; 1993 Oct; 53(19):4670-5. PubMed ID: 7691400
[TBL] [Abstract][Full Text] [Related]
5. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.
Sers C; Husmann K; Nazarenko I; Reich S; Wiechen K; Zhumabayeva B; Adhikari P; Schröder K; Gontarewicz A; Schäfer R
Oncogene; 2002 Apr; 21(18):2829-39. PubMed ID: 11973642
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type.
Uyama T; Morishita J; Jin XH; Okamoto Y; Tsuboi K; Ueda N
J Lipid Res; 2009 Apr; 50(4):685-93. PubMed ID: 19047760
[TBL] [Abstract][Full Text] [Related]
7. Molecular interaction between K-Ras and H-REV107 in the Ras signaling pathway.
Han CW; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2017 Sep; 491(2):257-264. PubMed ID: 28743497
[TBL] [Abstract][Full Text] [Related]
8. Induction of murine H-rev107 gene expression by growth arrest and histone acetylation: involvement of an Sp1/Sp3-binding GC-box.
Roder K; Kim KH; Sul HS
Biochem Biophys Res Commun; 2002 May; 294(1):63-70. PubMed ID: 12054741
[TBL] [Abstract][Full Text] [Related]
9. Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture.
Topol LZ; Marx M; Laugier D; Bogdanova NN; Boubnov NV; Clausen PA; Calothy G; Blair DG
Mol Cell Biol; 1997 Aug; 17(8):4801-10. PubMed ID: 9234736
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.
Tchernitsa OI; Zuber J; Sers C; Brinckmann R; Britsch SK; Adams V; Schäfer R
Oncogene; 1999 Sep; 18(39):5448-54. PubMed ID: 10498898
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway.
Wang CH; Shyu RY; Wu CC; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM
J Biomed Sci; 2014 May; 21(1):36. PubMed ID: 24884338
[TBL] [Abstract][Full Text] [Related]
12. Expression of ril, a novel LIM domain gene, is down-regulated in Hras-transformed cells and restored in phenotypic revertants.
Kiess M; Scharm B; Aguzzi A; Hajnal A; Klemenz R; Schwarte-Waldhoff I; Schäfer R
Oncogene; 1995 Jan; 10(1):61-8. PubMed ID: 7824279
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
14. hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors.
Siegrist S; Féral C; Chami M; Solhonne B; Mattéi MG; Rajpert-De Meyts E; Guellaën G; Bulle F
Oncogene; 2001 Aug; 20(37):5155-63. PubMed ID: 11526504
[TBL] [Abstract][Full Text] [Related]
15. Silencing of the mouse H-rev107 gene encoding a class II tumor suppressor by CpG methylation.
Roder K; Latasa MJ; Sul HS
J Biol Chem; 2002 Aug; 277(34):30543-50. PubMed ID: 12055182
[TBL] [Abstract][Full Text] [Related]
16. Novel revertants of H-ras oncogene-transformed R6-PKC3 cells.
Krauss RS; Guadagno SN; Weinstein IB
Mol Cell Biol; 1992 Jul; 12(7):3117-29. PubMed ID: 1535685
[TBL] [Abstract][Full Text] [Related]
17. [Rat embryo fibroblasts transformed by complementation with oncogenes E1A+E1B-19 and E1A+cHa-ras differ in the ability to realize the G1/S block in serum free media].
Brichkina AI; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Tsitologiia; 2001; 43(11):1024-30. PubMed ID: 11840777
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ras-mediated transformation. Differential expression of genes encoding extracellular matrix proteins in normal, transformed and revertant cells.
Hajnal A; Klemenz R; Schäfer R
Adv Enzyme Regul; 1993; 33():267-80. PubMed ID: 8356912
[TBL] [Abstract][Full Text] [Related]
19. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl NE; Ruley HE
Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
[TBL] [Abstract][Full Text] [Related]
20. [Constitutive activity of MAP kinase cascades in REF cells transformed by E1A and cHa-ras oncogenes].
Svetlikova SB; Abramova MV; Kukushkin AN; Darieva ZA; Pospelova TV; Pospelov VA
Tsitologiia; 2001; 43(10):961-8. PubMed ID: 11769129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
